Sector ratings Bio-Rad Laboratories, Inc.

Stocks

Market Closed - NYSE Other stock markets 04:00:03 12/08/2026 HKT			5-day change	1st Jan Change
356.25 ^USD	+0.48%		+7.02%	+17.58%

08-07	RBC Adjusts PT on Bio-Rad Laboratories to $390 From $370, Maintains Outperform Rating	MT
08-05	RBC Adjusts Price Target on Bio-Rad Laboratories to $370 From $320, Maintains Outperform Rating	MT

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	ESG MSCI	Global Valuation
BIO-RAD LABORATORIES, INC.	9.43B	BBB
ABBOTT LABORATORIES	190B	BBB
MEDTRONIC PLC	116B	BBB
CENCORA, INC.	63.71B	AA
HOYA CORPORATION	55.13B	AAA
BECTON, DICKINSON AND COMPANY	49.41B	A
DEXCOM, INC.	33.79B	BBB
MEDLINE INC.	30.74B	A
WEST PHARMACEUTICAL SERVICES, INC.	24.73B	AA
TERUMO CORPORATION	23.85B	AA
STERIS PLC	23.23B	AAA	-
SARTORIUS STEDIM BIOTECH	20.25B	BBB
ZIMMER BIOMET HOLDINGS, INC.	18.55B	A
FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED	14.71B	A
SOLVENTUM CORPORATION	14.32B	BBB
BAXTER INTERNATIONAL INC.	14.27B	A
ALIGN TECHNOLOGY, INC.	12.29B	A
GLOBUS MEDICAL, INC.	11.43B	CCC
INSULET CORPORATION	10.04B	A
REPLIGEN CORPORATION	9.3B	AA
Average	37.26B	A
Weighted average by Cap.		A